Nephros (NASDAQ:NEPH) Trading 1.3% Higher – Should You Buy?

Nephros, Inc. (NASDAQ:NEPH) shares traded up 1.3% on Monday . The stock traded as high as $1.65 and last traded at $1.60. 28,392 shares were traded during trading, an increase of 168% from the average session volume of 10,607 shares. The stock had previously closed at $1.58.

Wall Street Analysts Forecast Growth

Separately, Benchmark reiterated a “speculative buy” rating and issued a $5.00 price target on shares of Nephros in a research note on Tuesday, November 12th.

Nephros Trading Up 1.3 %

The business’s 50 day simple moving average is $1.56 and its 200 day simple moving average is $1.67. The firm has a market capitalization of $16.81 million, a PE ratio of -17.72 and a beta of 1.19.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP bought a new stake in shares of Nephros, Inc. (NASDAQ:NEPH) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned 0.17% of Nephros at the end of the most recent reporting period. Institutional investors own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.